CareRay(SH:688607)2025-02-24 11:20Financial Performance - Total revenue for 2024 reached 293.90 million yuan, an increase of 7.36% compared to the previous year[2] - Operating profit for 2024 was 16.56 million yuan, up 19.74% year-over-year[2] - Net profit attributable to shareholders of the parent company was 17.48 million yuan, reflecting a growth of 13.42% from the previous year[2] - The net profit attributable to shareholders after deducting non-recurring gains and losses was 5.73 million yuan, a significant increase of 491.45% year-over-year[2] - Basic earnings per share for 2024 were 0.20 yuan, up 17.37% from 0.17 yuan in the previous year[2] Assets and Equity - Total assets at the end of the reporting period were 972.29 million yuan, an increase of 2.64% compared to the beginning of the period[5] - Shareholders' equity attributable to the parent company was 861.48 million yuan, up 0.39% year-over-year[5] - The weighted average return on net assets increased by 0.22 percentage points to 2.03%[2] Revenue Growth Factors - The company attributed revenue growth to new product development, market expansion, and enhanced product competitiveness[4] Financial Reporting - The financial data presented is preliminary and unaudited, with final figures to be confirmed in the annual report[6]